Eli Lilly

  • Court Trials Unnerve HIV Propagandists

    It began in 2009 with Eneydi Torres.  Accused of exposing several men to HIV, Florida prosecutors threatened Torres with decades in prison unless she accepted their plea deal.  But when asked to prove the reliability of HIV testing, prosecutors abruptly reduced their offer of 15 years in state prison to five days of unsupervised probation. (more…)

    Post to Twitter Tweet This Post

  • More Prosecutors Dropping Criminal HIV Charges

    In another defeat for AIDS propagandists, Louisiana prosecutors have dropped all HIV-related criminal charges against a Louisiana woman.  According to attorney Jake Lemmon, Jefferson Parish prosecutors dropped all (more…)

    Post to Twitter Tweet This Post

  • When Pharma Profits Outweigh Penalties

    Prosecutor Michael Loucks remembers clearly when attorneys for Pfizer, the world’s largest drug company, looked across the table and promised it wouldn’t break the law again.  It was January 2004, and the lawyers were negotiating in a conference room on the ninth floor of the federal courthouse in Boston, where Loucks was head of the health-care fraud unit (more…)

    Post to Twitter Tweet This Post

  • Jail Time for Executives Might Stop Drug Crimes

    March 17 (Bloomberg) — If a surgeon cuts open your chest and implants a device meant to shock your heart into beating regularly, you are counting on the thing not short-circuiting.  You assume every aspect of its manufacture, each change in the process, has been reviewed and approved by proper authorities. If malfunctions turn up, surely the company will so report. (more…)

    Post to Twitter Tweet This Post

  • Congress Doth Protest Too Much

    Vera Sharav of the Alliance for Human Research Protection asks why the discovery of defective cars are front page news while defective FDA-approved prescription drugs are accepted as part of life’s risk: (more…)

    Post to Twitter Tweet This Post

  • JAMA Reports SSRI Scam

    Twenty-two years after the US marketing of Prozac, which changed the marketing, prescribing and widespread consumption of psychoactive drugs, a meta-analysis of six large studies published in the Journal of the Medical Association (JAMA) confirms that industry’s blockbuster drugs, SSRI antidepressants, were unable to outperform placebos for moderate sumptions of depression. (more…)

    Post to Twitter Tweet This Post

<<prev

AT ISSUE

OMSJ Demands Editors to Depublish Gallo's Reports

TAKE ACTION

KEY ISSUES

    MORE